Document Detail

Osteopontin, a new prognostic biomarker in patients with chronic heart failure.
MedLine Citation:
PMID:  19808269     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Osteopontin, a glycoprotein that can be detected in plasma, was found to be upregulated in several animal models of cardiac failure and may thus represent a new biomarker that facilitates risk stratification in patients with heart failure. We therefore tested whether osteopontin plasma levels are elevated in patients with chronic heart failure and whether they provide independent prognostic information. METHODS AND RESULTS: We analyzed osteopontin plasma levels in 420 patients with chronic heart failure due to significantly impaired left ventricular systolic function and correlated the results with disease stage and prognostic information (median follow-up of 43 months). We found that osteopontin plasma levels were significantly elevated in patients with heart failure as compared with healthy control subjects (532 versus 382 ng/mL, P=0.008), irrespective of heart failure origin (ischemic versus dilated cardiomyopathy). Furthermore, osteopontin levels were higher in patients with moderate to severe heart failure than in patients with no or mild symptoms (672 ng/mL for New York Heart Association class III/IV versus 479 ng/mL for class I/II, P<0.0001). Estimated 4-year death rates in patients with osteopontin levels above or below a cutoff value derived from receiver operating characteristic analyses were 56.5% and 28.4%, respectively (hazard ratio 3.4, 95% confidence interval 2.2 to 5.3, P<0.0001). In a multivariable model that included demographic, clinical, and biochemical parameters such as N-terminal prohormone brain natriuretic peptide, osteopontin emerged as an independent predictor of death (hazard ratio 2.3, 95% confidence interval 1.4 to 3.5, P<0.001). CONCLUSIONS: Our findings suggest that osteopontin might be useful as a novel prognostic biomarker in patients with chronic heart failure.
Mark Rosenberg; Christian Zugck; Manfred Nelles; Claus Juenger; Derk Frank; Andrew Remppis; Evangelos Giannitsis; Hugo A Katus; Norbert Frey
Related Documents :
10607509 - Alterations in vascular reactivity in isolated vessel segments from dogs with naturally...
23811839 - Integrating the knowledge: strength and limitations of echo techniques to diagnose and ...
19133159 - How 40 kilograms of fluid retention can be overlooked: two case reports.
24313269 - Alternative techniques for left ventricular pacing in cardiac resynchronization therapy.
9419669 - Additive hemodynamic and electrophysiologic effects of repeated intracoronary contrast ...
25242299 - The utility of fully automated real-time three-dimensional echocardiography in the eval...
14662229 - Long-term outcome in fetuses with cardiac arrhythmias.
18682489 - Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis...
2888599 - Drug-induced left ventricular failure in patients with pulmonary disease. endomyocardia...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Circulation. Heart failure     Volume:  1     ISSN:  1941-3297     ISO Abbreviation:  Circ Heart Fail     Publication Date:  2008 May 
Date Detail:
Created Date:  2009-10-07     Completed Date:  2009-11-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101479941     Medline TA:  Circ Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  43-9     Citation Subset:  IM    
Department of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Case-Control Studies
Chronic Disease
Heart Failure / blood*
Middle Aged
Osteopontin / blood*
Predictive Value of Tests
Risk Assessment
Risk Factors
Reg. No./Substance:
0/Biological Markers; 106441-73-0/Osteopontin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsarta...
Next Document:  Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from th...